Retractable Technologies Total Non-Operating Income/Expense 2010-2024 | RVP

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Retractable Technologies total non-operating income/expense from 2010 to 2024. Total non-operating income/expense can be defined as the sum of all non-operating expenses for the given industry.

Retractable Technologies Total Non-Operating Income/Expense 2010-2024 | RVP

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Retractable Technologies total non-operating income/expense from 2010 to 2024. Total non-operating income/expense can be defined as the sum of all non-operating expenses for the given industry.

Related Stocks
Company Name	Market Cap
McKesson (MCK)	$79.1B
Becton Dickinson (BDX)	$64.7B
Cardinal Health (CAH)	$29.5B
West Pharmaceutical Services (WST)	$22.9B
Cooper (COO)	$20.1B
Labcorp (LH)	$20B
Align Technology (ALGN)	$16.9B
Henry Schein (HSIC)	$9.4B
Merit Medical Systems (MMSI)	$6.1B
DENTSPLY SIRONA (XRAY)	$3.7B
CONMED (CNMD)	$2.3B
Patterson (PDCO)	$1.8B
STAAR Surgical (STAA)	$1.3B
Lifevantage (LFVN)	$178M
Pro-Dex (PDEX)	$152M